Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Dedicare's Interim Report 1 January - 30 June 2024: A still-challenging market burdened the second quarter


News provided by

Dedicare

12 Jul, 2024, 07:15 GMT

Share this article

Share toX

Share this article

Share toX

STOCKHOLM, July 12, 2024 /PRNewswire/ -- 

Second quarter 2024

  • Net sales SEK 439.6 million (478.9)
  • EBITA SEK 21.2 million (38.0), adjusted for non-recurring items SEK 24.1 million (38.0)
  • EBITA margin 4.8 percent (7.9), adjusted for non-recurring items 5.5 percent (7.9)
  • EBIT SEK 18.9 million (34.4), adjusted for non-recurring items SEK 21.8 million (34.4)
  • EBIT margin 4.3 percent (7.2), adjusted for non-recurring items 5.0 percent (7.2)
  • Profit after financial items SEK 19.6 million (29.8)
  • Profit for the period SEK 15.3 million (22.9)
  • Basic earnings per share SEK 1.60 (2.40)
  • Diluted earnings per share SEK 1.59 (2.37)

The period January - June 2024

  • Net sales SEK 869.8 million (982.1)
  • EBITA SEK 38.6 million (79.6), adjusted for non-recurring items SEK 41.5 million (79.6)
  • EBITA margin 4.4 percent (8.1), adjusted for non-recurring items 4.8 percent (8.1)
  • EBIT SEK 34.0 million (72.4 ), adjusted for non-recurring items SEK 36.9 million (72.4)
  • EBIT margin 3.9 percent (7.4), adjusted for non-recurring items 4.2 percent (7.4)
  • Profit after financial items SEK 33.1 million (61.2)
  • Profit for the period SEK 25.8 million (47.5)
  • Basic earnings per share SEK 2.70 (4.97)
  • Diluted earnings per share SEK 2.67 (4.92)

Performance measures 

Chief Executive Officer's statement

"A still-challenging market burdened the second quarter"

"As previously reported, the challenging start to the year continued in the second quarter. The Swedish healthcare market staffing market was slow and hard to navigate due to the implementation of its new nationwide deal, limits on contracting, a healthcare strike and overtime ban. Norway, our largest market, remains strong, but was negatively impacted by greater price pressure. Net sales and EBIT were down in the quarter on the previous year. However, the second quarter of the year was stronger than the first, both in terms of net sales and profitability. To adapt our business to prevailing market conditions, we initiated a cost savings programme in the quarter, while continuing to invest in markets with healthy demand.

The Dedicare group's net sales were SEK 439.6 million in the second quarter, down 8.2 percent year on year. Our EBITA adjusted for non-recurring items decreased to SEK 24.1 million (38.0). Our EBITA margin adjusted for non-recurring items was 5.5 percent (7.9). The reduced sales year on year are mainly due to a weaker healthcare staffing market in Sweden. Our earnings downturn is due to both a poor Swedish market and price pressure on the Norwegian market. In May, we decided on a cost savings programme, which we plan to generate some SEK 15 million of savings yearly, with full effect from the fourth quarter of this year. Earnings in the quarter were charged with non-recurring costs of SEK 2.9 million from the programme. We also made a change to our management in the quarter, with Eva Brunnberg, Managing Director of Dedicare Sweden leaving the company, and Bård Kristiansen, MD of Dedicare Norway, taking over as Interim MD of Dedicare Sweden. The process of hiring a new MD for Dedicare Sweden is ongoing.

Market conditions remained positive in Norway in the quarter, and we were also delighted to be recognised as Norway's Best Workplace by Great Place to Work for the second consecutive year. Meanwhile, more intense competition and increased price pressure is persisting in Norway, as we've witnessed in recent quarters. Primarily, this impacted us in the quarter through lower profitability. Net sales for Norway were SEK 282.3 million (280.5), while EBITA decreased to SEK 22.2 million (29.8), corresponding to an EBITA margin of 7.9 percent (10.6).

In Norway, we're continuing to move forward from our market-leading position, and in the quarter, received the really positive news that we'd been reappointed to provide doctors, specialist physicians, psychologists and other healthcare staff to all hospitals across all Norway's healthcare regions in the country's nationwide healthcare tender. This is more far-reaching than the current deal. In nurse staffing, demand remained brisk after the new deal in 2023. Our preschool business Acapedia, with its new office in Kristiansand, also continued its positive progress in the quarter.

In Sweden, the challenges in healthcare staffing persisted, and the quarter was weak. Net sales were down by 28.2 percent to SEK 87.4 million (121.8), and EBITA adjusted for non-recurring items related to our cost savings programme was down to SEK 0.5 million (6.0), with an adjusted EBITA margin of 0.6 percent (4.9). Before adjusting for non-recurring items, our EBITA was a negative SEK -2.4 million (6.0). Apart from the regions' limits on healthcare staff contracting, which are affecting the whole market, a healthcare strike and overtime ban complicated the situation. The implementation of the new nationwide deal also meant customers placing holiday staff orders late, just ahead of the summer, which ultimately made it difficult for us to fill all orders because of staff shortages. We anticipate the challenging position in Sweden's healthcare staffing market persisting in the third quarter. As mentioned above, we've now taken action, both organisationally and through our cost savings programme. We also note that as a company, our diversity is a strength—in Sweden, apart from healthcare staffing, we're also active in life science and social work staffing. Our life science consulting business grew in the quarter, in Sweden and Denmark. To consolidate our investment, we reorganised this business area at a pan-Nordic level, with Anna-Lena Mann appointed as MD in the quarter to head up our Nordic Life Science business.

I'd like to take this opportunity to refer to an interesting report by independent research firm Sirona, published in June. Misunderstandings surround the debate over the contracting limits imposed by Sweden's healthcare regions-not least often huge exaggeration of the costs of contracting in doctors and nurses. While contracted staff do cost more than direct employees, the difference is actually far less than frequently cited in the debate. For example, the report, ordered by the Employers' Organisation for the Swedish Service Sector (Kompetensföretagen), showed that in smaller towns, the cost of a contracted doctor was 11 percent higher than one employed by the regional authority, while the cost of a contracted nurse was 27 percent higher. The report states that the extra cost of contracting in doctors and nurses amounts is only just over 1 percent of the regions' total staff spend of SEK182 billion, 1 percent that creates huge value in healthcare through more flexibility and shorter waiting lists! Healthcare staffing companies are here to solve problems, and we do so at a reasonable cost for Sweden's healthcare sector.

In Denmark, doctor staffing is continuing its good progress, and we also had our long-term deal for midwives extended. However, the segment is still adversely impacted by limits on nurses on long-term contract, a contributor to the segment's second-quarter net sales declining to SEK 58.6 million (67.5). Our EBITA margin expanded to SEK 7.5 percent (6.1).

Our initiatives in the UK segment, which consist of international recruitment and staffing, and of doctor staffing in the UK, are continuing. In the quarter, we achieved growth of 27 percent and net sales of SEK 13.5 million (10.6). We invested in new staff in sales, business development and recruitment in the quarter, which impacted our profitability, and our EBITA margin was down to 3.0 percent (7.5).

Our international recruitment and staffing projects performed well, and we secured a new deal. We've also decided on an initiative in Ireland, where we're seeing higher demand. However, there was a general demand downturn in doctor staffing on the UK market in the quarter.

I can round up a quarter for the group with continued healthy demand and several significant new deals, but also more competition and price pressure in Norway, our largest market, while Sweden's healthcare staffing market was weak and challenging. This is a market situation we've been reporting for several quarters now, but I have to accept, will unfortunately continue in the third quarter at least. Meanwhile, we've taken action, and I'm proud and pleased how professionally and quickly our staff have been able to navigate through the prevailing market conditions. This is a critical capability for our organisation so we can keep progressing and achieving our long-term goals."

Krister Widström, Managing Director and CEO

This information is mandatory for Dedicare AB (publ) to publish pursuant to the EU Market Abuse Regulation (MAR) and the Swedish Securities Markets Act. This information was submitted for publication through the agency of the above contact at 8 a.m. CET on 12 July 2024. 

CONTACT: 
Krister Widström, CEO & Managing Director, +46 (0)70 526 79 91
Anette Sandsjö, CFO, +46 (0)73 343 44 68

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/dedicare/r/interim-report-1-january---30-june-2024--a-still-challenging-market-burdened-the-second-quarter,c4014274

The following files are available for download:

https://mb.cision.com/Main/1178/4014274/2913336.pdf

Interim Report - Q2 2024 Dedicare AB

https://news.cision.com/dedicare/i/performance-measures,c3319353

Performance measures

Modal title

Also from this source

Dedicare's Year-end Report 1 January - 31 December 2024: Continued weak progress in the fourth quarter concluded a challenging 2024

Fourth quarter 2024 Net sales SEK 389.0 million (464.1) EBITA SEK 19.5 million (41.6), adjusted for non-recurring items SEK 12.8 million (30.7) EBITA ...

Dedicare's Interim Report 1 January - 30 September 2024: Market still challenging in the third quarter

Third quarter 2024 Net sales SEK 460.9 million (524.5) EBITA SEK 11.2 million (40.6), adjusted for non-recurring items SEK 19.0 million (40.6) EBITA...

More Releases From This Source

Explore

Human Resource & Workforce Management

Human Resource & Workforce Management

Health Care & Hospitals

Health Care & Hospitals

Accounting News & Issues

Accounting News & Issues

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.